EP0000106B1 - 2-alkyl nicotinoids and processes for their production and use - Google Patents
2-alkyl nicotinoids and processes for their production and use Download PDFInfo
- Publication number
- EP0000106B1 EP0000106B1 EP78300040A EP78300040A EP0000106B1 EP 0000106 B1 EP0000106 B1 EP 0000106B1 EP 78300040 A EP78300040 A EP 78300040A EP 78300040 A EP78300040 A EP 78300040A EP 0000106 B1 EP0000106 B1 EP 0000106B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- methyl
- compound according
- formula
- compound
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 24
- 230000008569 process Effects 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 41
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 17
- -1 N-methyl-2-pyrrolidinyl Chemical group 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- VNCAJINVSUVLQL-NSHDSACASA-N 2-methyl-3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1C VNCAJINVSUVLQL-NSHDSACASA-N 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 11
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 10
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 8
- 230000000749 insecticidal effect Effects 0.000 claims description 8
- 239000002917 insecticide Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000012279 sodium borohydride Substances 0.000 claims description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 8
- 239000012312 sodium hydride Substances 0.000 claims description 8
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 8
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- OOMLXJAEGLHIEP-UHFFFAOYSA-N 2,6-dimethyl-3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=C(C)N=C1C OOMLXJAEGLHIEP-UHFFFAOYSA-N 0.000 claims description 4
- NXOCBSTXRGDTGJ-UHFFFAOYSA-N 2-methyl-3-piperidin-2-ylpyridine Chemical compound CC1=NC=CC=C1C1NCCCC1 NXOCBSTXRGDTGJ-UHFFFAOYSA-N 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 4
- 239000000010 aprotic solvent Substances 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical group [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- XQNFBFCZYRFBNR-UHFFFAOYSA-N 2-ethyl-3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CCC1=NC=CC=C1C1N(C)CCC1 XQNFBFCZYRFBNR-UHFFFAOYSA-N 0.000 claims description 2
- VNNVJSKAMIHQII-UHFFFAOYSA-N 2-ethyl-3-pyrrolidin-2-ylpyridine Chemical compound CCC1=NC=CC=C1C1NCCC1 VNNVJSKAMIHQII-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 229910052731 fluorine Chemical group 0.000 claims description 2
- 239000011737 fluorine Chemical group 0.000 claims description 2
- ULITUPMHIDVLLV-UHFFFAOYSA-N formonitrile;sodium Chemical compound [Na].N#C ULITUPMHIDVLLV-UHFFFAOYSA-N 0.000 claims description 2
- 230000000269 nucleophilic effect Effects 0.000 claims description 2
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 2
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 150000004678 hydrides Chemical class 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 67
- 239000000243 solution Substances 0.000 description 49
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- 239000003921 oil Substances 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 230000002829 reductive effect Effects 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 230000003595 spectral effect Effects 0.000 description 13
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 12
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical class CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 239000012043 crude product Substances 0.000 description 11
- 229960002715 nicotine Drugs 0.000 description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000029936 alkylation Effects 0.000 description 6
- 238000005804 alkylation reaction Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 231100001225 mammalian toxicity Toxicity 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- PYPGFSYKBFXDCA-UHFFFAOYSA-N 1-methylpyrrolidine-2-carbonitrile Chemical compound CN1CCCC1C#N PYPGFSYKBFXDCA-UHFFFAOYSA-N 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 230000008707 rearrangement Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PNNMNLLCHYHPBH-UHFFFAOYSA-N 2-methyl-3-pyrrolidin-2-ylpyridine Chemical compound CC1=NC=CC=C1C1NCCC1 PNNMNLLCHYHPBH-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 4
- 229910000564 Raney nickel Inorganic materials 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- BSLOVEUOGSDAIH-UHFFFAOYSA-N 2-(1-pyrrolidin-1-ylethyl)pyridine Chemical compound C=1C=CC=NC=1C(C)N1CCCC1 BSLOVEUOGSDAIH-UHFFFAOYSA-N 0.000 description 3
- XLXANWGTOZKKAZ-UHFFFAOYSA-N 2-(pyrrolidin-1-ylmethyl)pyridine Chemical compound C=1C=CC=NC=1CN1CCCC1 XLXANWGTOZKKAZ-UHFFFAOYSA-N 0.000 description 3
- OFQCQIGMURIECL-UHFFFAOYSA-N 2-[2-(diethylamino)ethyl]-2',6'-dimethylspiro[isoquinoline-4,4'-oxane]-1,3-dione;phosphoric acid Chemical compound OP(O)(O)=O.O=C1N(CCN(CC)CC)C(=O)C2=CC=CC=C2C21CC(C)OC(C)C2 OFQCQIGMURIECL-UHFFFAOYSA-N 0.000 description 3
- CQZIEDXCLQOOEH-UHFFFAOYSA-N 3-bromopropanenitrile Chemical compound BrCCC#N CQZIEDXCLQOOEH-UHFFFAOYSA-N 0.000 description 3
- 241001124076 Aphididae Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000003637 basic solution Substances 0.000 description 3
- OJPUAKBCOCCESD-UHFFFAOYSA-M benzenesulfonate;2-[1-(pyridin-2-ylmethyl)pyrrolidin-1-ium-1-yl]acetonitrile Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1.C=1C=CC=NC=1C[N+]1(CC#N)CCCC1 OJPUAKBCOCCESD-UHFFFAOYSA-M 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- SSOVHFPWMPUQOS-UHFFFAOYSA-N cyanomethyl benzenesulfonate Chemical compound N#CCOS(=O)(=O)C1=CC=CC=C1 SSOVHFPWMPUQOS-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical group 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- OFPWMRMIFDHXFE-UHFFFAOYSA-N 2-(bromomethyl)pyridine Chemical compound BrCC1=CC=CC=N1 OFPWMRMIFDHXFE-UHFFFAOYSA-N 0.000 description 2
- JQDNCGRNPYKRAO-UHFFFAOYSA-N 2-(bromomethyl)pyridine;hydron;bromide Chemical compound Br.BrCC1=CC=CC=N1 JQDNCGRNPYKRAO-UHFFFAOYSA-N 0.000 description 2
- WQDQDLHATTVJSW-UHFFFAOYSA-N 2-ethyl-5-(1-methylpyrrolidin-2-yl)pyridine Chemical compound C1=NC(CC)=CC=C1C1N(C)CCC1 WQDQDLHATTVJSW-UHFFFAOYSA-N 0.000 description 2
- SWNIAVIKMKSDBJ-NSHDSACASA-N 2-methyl-5-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CN1CCC[C@H]1C1=CC=C(C)N=C1 SWNIAVIKMKSDBJ-NSHDSACASA-N 0.000 description 2
- AJCBVBSUGQKYPJ-UHFFFAOYSA-N 4-(2-methylpyridin-3-yl)-4-oxobutanenitrile Chemical compound CC1=NC=CC=C1C(=O)CCC#N AJCBVBSUGQKYPJ-UHFFFAOYSA-N 0.000 description 2
- 0 CC1N(*)CCC1 Chemical compound CC1N(*)CCC1 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 241000257226 Muscidae Species 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940075930 picrate Drugs 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 description 1
- TXFGHOFIVBJLFJ-UHFFFAOYSA-N 1-(2,6-dimethylpyridin-3-yl)-n,n-dimethyl-2-phenylethanamine Chemical compound C=1C=C(C)N=C(C)C=1C(N(C)C)CC1=CC=CC=C1 TXFGHOFIVBJLFJ-UHFFFAOYSA-N 0.000 description 1
- XRNVFBWUWNIMST-UHFFFAOYSA-N 1-methyl-3,6-dihydro-2h-pyridine-2-carbonitrile Chemical compound CN1CC=CCC1C#N XRNVFBWUWNIMST-UHFFFAOYSA-N 0.000 description 1
- NFPKIKNBLVYHSH-UHFFFAOYSA-N 2,8-bis(2-methylpyridin-3-yl)-5-oxononanedinitrile Chemical compound CC1=NC=CC=C1C(C#N)CCC(=O)CCC(C#N)C1=CC=CN=C1C NFPKIKNBLVYHSH-UHFFFAOYSA-N 0.000 description 1
- WJFDCFHWFHCLIW-UHFFFAOYSA-N 2-(bromomethyl)-6-methylpyridine Chemical compound CC1=CC=CC(CBr)=N1 WJFDCFHWFHCLIW-UHFFFAOYSA-N 0.000 description 1
- VJDWDYXOGHHILO-UHFFFAOYSA-N 2-(bromomethyl)-6-methylpyridine;hydrobromide Chemical compound Br.CC1=CC=CC(CBr)=N1 VJDWDYXOGHHILO-UHFFFAOYSA-N 0.000 description 1
- UKNNMIJHBRRZDK-UHFFFAOYSA-N 2-(bromomethyl)-6-phenylpyridine Chemical compound BrCC1=CC=CC(C=2C=CC=CC=2)=N1 UKNNMIJHBRRZDK-UHFFFAOYSA-N 0.000 description 1
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
- VNCAJINVSUVLQL-UHFFFAOYSA-N 2-methyl-3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1C VNCAJINVSUVLQL-UHFFFAOYSA-N 0.000 description 1
- GREMYQDDZRJQEG-UHFFFAOYSA-N 2-methyl-6-phenylpyridine Chemical compound CC1=CC=CC(C=2C=CC=CC=2)=N1 GREMYQDDZRJQEG-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- KCOFDGQOFMFHHM-UHFFFAOYSA-N 2-pyridin-2-yl-2-pyrrolidin-1-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)N1CCCC1 KCOFDGQOFMFHHM-UHFFFAOYSA-N 0.000 description 1
- VFYVKROSRGWGGF-UHFFFAOYSA-N 2-pyridin-2-yl-2-pyrrolidin-1-ylpropanenitrile Chemical compound C=1C=CC=NC=1C(C#N)(C)N1CCCC1 VFYVKROSRGWGGF-UHFFFAOYSA-N 0.000 description 1
- ACQGCWVZJJQSBQ-UHFFFAOYSA-N 4-(2-methylpyridin-3-yl)-2-pyrrolidin-1-ylbutanenitrile Chemical compound CC1=NC=CC=C1CCC(C#N)N1CCCC1 ACQGCWVZJJQSBQ-UHFFFAOYSA-N 0.000 description 1
- CQPGDDAKTTWVDD-UHFFFAOYSA-N 4-bromobutanenitrile Chemical compound BrCCCC#N CQPGDDAKTTWVDD-UHFFFAOYSA-N 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical class NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 238000005863 Friedel-Crafts acylation reaction Methods 0.000 description 1
- 238000003547 Friedel-Crafts alkylation reaction Methods 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 238000007137 Sommelet-Hauser rearrangement reaction Methods 0.000 description 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- ICAIHGOJRDCMHE-UHFFFAOYSA-O ammonium cyanide Chemical compound [NH4+].N#[C-] ICAIHGOJRDCMHE-UHFFFAOYSA-O 0.000 description 1
- 229930014345 anabasine Natural products 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- QXJSBOQRODCRKF-UHFFFAOYSA-M benzenesulfonate;cyanomethyl-dimethyl-[(6-methylpyridin-2-yl)methyl]azanium Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1.CC1=CC=CC(C[N+](C)(C)CC#N)=N1 QXJSBOQRODCRKF-UHFFFAOYSA-M 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- QWJNFFYFEKXZBF-UHFFFAOYSA-N cyanocyanamide Chemical compound N#CNC#N QWJNFFYFEKXZBF-UHFFFAOYSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000007255 decyanation reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- ZOAMBXDOGPRZLP-UHFFFAOYSA-N indole-3-acetamide Chemical compound C1=CC=C2C(CC(=O)N)=CNC2=C1 ZOAMBXDOGPRZLP-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- OVRBBDDZYQCMED-UHFFFAOYSA-N n,n-dimethyl-1-(6-methylpyridin-2-yl)methanamine Chemical compound CN(C)CC1=CC=CC(C)=N1 OVRBBDDZYQCMED-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- CNHUCBXIKSSPHQ-UHFFFAOYSA-N perchloric acid;pyrrolidine Chemical compound C1CCNC1.OCl(=O)(=O)=O CNHUCBXIKSSPHQ-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- AXSWDVPMPIZVKD-UHFFFAOYSA-L potassium sodium hydrogen carbonate chloride Chemical class [Na+].[Cl-].[K+].OC([O-])=O AXSWDVPMPIZVKD-UHFFFAOYSA-L 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical class N1(CCCC=C1)* 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
Definitions
- the present invention relates to a group of novel nicotine analogues containing alkyl substituents ortho to the pyrrolidine ring.
- the synthetic procedures disclosed herein for the production of nicotine analogues constitute considerably shorter and more practical routes than those previously proposed.
- the novel compounds produced by the methods of the present invention are useful as insecticides.
- Nicotine has been used as an insecticide for many years (see, for example, D. E. H. Frear, "Chemistry of the Pesticides," 3rd Ed., D. Van Nostrand Co., New York, 1955). Although a number of natural as well as synthetic nicotinoids have been screened with regard to insecticidal activity, the vast majority are significantly less active than nicotine [see J. Yamamoto et al., Agr. Biol. Chem. 32, 1341 (1968)]. The analogues of nicotine which have been tested involve either the alteration of the pyrrolidine moiety of the molecule, or the replacement of the pyridine ring with a substituted aromatic ring.
- the paper describes a new synthetic process for the production of 2-alkyl-3-acylpyridines and 2-alkyl-3-formylpyridines via [2,3]-sigmatropic rearrangement of 1-cyanomethyl-1-( ⁇ -alkyl-2-picolyl) pyrrolidinium salts.
- the versatility of this procedure is evidenced by the fact that the a-cyanoamine initially obtained can be hydrolyzed to an aldehyde, reductively cleaved to an amine, or alkylated and hydrolyzed to a ketone.
- the present invention concerns new and improved processes for the production of compounds represented by the formula: wherein R, is hydrogen, lower alkyl, phenyl, alkaryl or phenylalkyl, R 2 is lower alkyl or phenylalkyl, and R 3 is a heterocyclic group represented by the formula: wherein R 4 is hydrogen or lower alkyl, R s is lower alkyl, and n is one or two.
- the invention also includes the resulting compounds of this formula, except that in the case of 2-methylnicotine it extends only to the isolated, substantially pure compound.
- the present invention may make use of novel intermediate products, some of which are useful in the production of compounds of Formula I and are represented by the formula: wherein R 1 and R 2 are the same as defined in Formula I and R 6 is represented by the formula: wherein R 7 is hydrogen, lower alkyl, ⁇ -cyanoalkyl or phenylalkyl, and each R 8 is independently selected from lower alkyl or when taken together with a connecting element, a heterocyclic structure is formed.
- R 7 is hydrogen, lower alkyl, ⁇ -cyanoalkyl or phenylalkyl
- each R 8 is independently selected from lower alkyl or when taken together with a connecting element, a heterocyclic structure is formed.
- the intermediates are readily prepared by the method depicted in Scheme II hereinbelow.
- lower alkyl means straight-chain or branched alkyl groups with 1 to 6 carbon atoms, for example methyl, ethyl, propyl, isopropyl, butyl, and the like, with methyl being preferred.
- Alkaryl means aromatic radicals containing between 7 and 10 carbon atoms such as tolyl or xylyl.
- Phenylalkyl includes radicals such as benzyl, phenylethyl or phenylpropyl.
- Heterocyclic structures are meant to include cyclic amines such as pyrrolidine, morpholine, pyridine or tetrahydropyridines.
- the compounds within the scope of the Formula I have two basic nitrogen atoms and can therefore form acid addition salts with inorganic and organic acids; for example, hydrochloric acid, acetic acid, maleic acid, p-toluenesulfonic acid or ethanesulfonic acid.
- the salts of the compounds within the scope of Formula I can also be in the form of hydrates, for example, mono, tri- or polyhydrate.
- the compounds of Formula I may be synthesized by two different but related processes.
- a 2-halomethyl or substituted methylpyridine represented by the formula: wherein R 1 is the same as defined in Formula I, R 2 , is hydrogen, C 1-5 alkyl, phenyl or phenylalkyl and X is halogen, such as bromine, chlorine, iodine, or fluorine, with bromine being preferred, is reacted with a 2-cyano-N-substituted heterocyclic of the formula: wherein R 4 and R 5 are lower alkyl and n is one or two, to give a 1-alkyl-1-(2-picolyl or 2-a-alkylpicolyl)-2-cyanopyrrolidinium halide or the corresponding 1,2,3,6-tetrahydropyridinium halide.
- the 2-haloalkylpyridine starting materials are readily available or may be synthesized by known methods.
- the 1-alkyl-2-cyanopyrrolidines are prepared by treatment of a 1-alkyl-2-pyrrolidinone with a reducing agent such as sodium aluminum hydride followed by reaction with ammonium cyanide.
- the 2 cyano-N-substituted 1,2,3,6-tetrahydropyridines are prepared according to methods described in J. Org. Chem., 29, 1647 (1964).
- the reaction is carried out by adding a 2-haloalkylpyridine to a 1-alkyl-2-cyanopyrrolidine dissolved in an aprotic polar solvent such as dimethylsulfoxide, acetonitrile, etc.
- an aprotic polar solvent such as dimethylsulfoxide, acetonitrile, etc.
- the reaction is allowed to continue until salt formation is complete as determined by, for example, thin layer chromatography.
- the [2,3]-rearrangement (Schemes I, below) of the pyrrolidine moiety is achieved by diluting the product (VII) obtained above with an aprotic solvent such as tetrahydrofuran, dimethylsulfoxide, hexamethylphosphoric triamide, acetonitrile, and the like, with tetrahydrofuran being preferred, and then adding a strong nonnucleophilic base such as potassium-tert-butoxide, potassium hydride, sodium hydride, sodium amide, and the like. After an appropriate reaction time of about 4 to about 8 hours, the product is isolated by standard extraction techniques known in the art.
- an aprotic solvent such as tetrahydrofuran, dimethylsulfoxide, hexamethylphosphoric triamide, acetonitrile, and the like
- a strong nonnucleophilic base such as potassium-tert-butoxide, potassium hydride, sodium hydride, sodium amide, and the like.
- the reaction can be carried out using a base such as sodium amide and liquid ammonia as the solvent.
- a base such as sodium amide and liquid ammonia as the solvent.
- the latter method minimizes formation of side products which occur in certain examples.
- the crude 2-alkyl-2'-cyano- nicotine product (VIII) isolated by standard techniques is then treated with a reducing agent such as lithium aluminum hydride, sodium borohydride, sodium cyanohydride and the like. Heating may be required to complete the reaction and the crude product is then isolated and may be further purified by standard techniques to yield the desired 2-alkylnicotinoids of Formula IX: wherein R 1 and n are the same as defined in Formulae I and II, R 2 is hydrogen, C 1-5 alkyl, phenyl or phenylalkyl and R 4 is lower alkyl.
- a 2-alkyl-3-(1-cyano-1-pyrrolidinylmethyl)pyridine (XIV) is generally not isolated, but its formation may be confirmed by pmr spectroscopy.
- the compounds of Formula XIV may then be treated with one equivalent of a strong base, followed by alkylation with a haloalkylnitrile, and acid hydrolysis to give a 2-methyl-3 pyridyl cyanoalkyl ketone of Formula XV.
- the ketone thus formed may be cyclized under reducing conditions to yield compounds of Formula (XVI).
- the reduction can be carried out catalytically, by means of noble metal catalyst, for example, by means of platinum, or by means of Raney nickel catalyst under elevated pressure, for example, under a pressure of more than 2 atmospheres.
- the compounds of Formula I obtained in the manner described above are unsubstituted at the nitrogen, i.e. R 4 is hydrogen.
- the a-cyanoamine resulting from the rearrangement may be reduced to the corresponding amine or treated with an organometallic reagent to form an alkylated amine.
- R 2 of Formula I is an alkyl group other than methyl, for example, ethyl or propyl
- the compound may be prepared by starting with the appropriate 2-a-alkylpicoline as previously described herein above (Scheme I and Scheme II), or in an alternate approach by further alkylation of R 2 .
- 2-methylnicotine may be readily converted to 2-ethylnicotine by treatment with phenyllithium followed by alkylation with a haloalkyl such as metholiodide.
- 2-methylnicotine may be converted to a 2-phenylalkylnicotine by treatment with phenyllithium and alkylation with a haloalkylphenyl moiety to yield a compound of Formula I, such as, for example, 2-phenylethyInicotine.
- the reaction mixture was cooled and the organic and aqueous phase separated.
- the aqueous phase was washed with 100 ml of ether.
- the ether and tetrahydrofuran phases were then combined and washed with two 100 ml portions of a saturated sodium chloride solution.
- the organic phase was dried over sodium sulfate and filtered preparatory to removal of solvent under reduced pressure.
- the residue was distilled to yield 10.0 g of 1-methyl-2-cyanopyrrolidine.
- the compound had a boiling point of 57-9° at 9.5 mm of Hg.
- the resulting oil was dissolved in 100 ml dimethylsulfoxide and 500 ml tetrahydrofuran and then cooled to -10°. To the solution was added 4.5 g (94 mmol) 50% sodium hydride dispersion. The reaction was stirred for 3.5 hours at 0° and 16 hours at room temperature. The reaction mixture was filtered and the solvent was removed under reduced pressure giving a tan oil containing some solid material. The oil was dissolved in a small amount of ether and the solution filtered to remove insolubles. The ether solution was washed three times with a basic saturated sodium chloride solution, dried over sodium sulfate, filtered and concentrated to give 14.96 g of an oil.
- the oil was dissolved in 300 ml 95% ethanol and 4.7 g (124 mmol) of sodium borohydride was added. The mixture was stirred at 0° for 1 hour and at room temperature for 2 hours. The reaction mixture was filtered and the precipitate was washed first with ethanol and then with ether. The filtrate was concentrated, taken up in ether and filtered to remove additional insolubles. The filtrate was extracted with three 20 ml portions of 20% acetic acid. The combined acid extracts were washed with ether, diluted with 11.3 ml of concentrated hydrochloric acid and concentrated to dryness. The residue was treated with 50% aqueous potassium hydroxide and extracted with three portions of ether. The ether extracts were combined and dried over sodium sulfate.
- the solution was concentrated to about 15 ml after which 30 ml dimethyl sulfoxide was added, and the reaction mixture was stirred for 21 hours.
- the solution was continuously extracted with ether and the ether insoluble residue was dissolved in methanol, transferred to a 500 ml three-necked flask, and evaporated in vacuo to dryness to give 7.33 g (79%) of a dark red semi-solid.
- Two hundred fifty ml of liquid ammonia was condensed into the flask and 1.23 g (31.4 mmol) of sodium amide was added. The reaction mixture was stirred at -60° for 30 minutes and then at reflux for 2 hours.
- the ammonia was allowed to boil off leaving a brown residue which was triturated with ether and the resulting ether solution was filtered, and concentrated to give 2.71 g of a brown oil.
- the oil was dissolved in 125 ml of 95% ethanol and 2.0 g of sodium borohydride was added. After stirring at room temperature for 8 hours, the ethanol was removed and the residue was dissolved in ether.
- the etheral solution was extracted with 5% hydrochloric acid, the acid solution was washed with ether, basified with aqueous potassium hydroxide, and extracted with ether. The ether extracts of the basic solution were combined, dried over magnesium sulfate, filtered, and the solvent was removed.
- 2-methylnicotine is treated with phenyllithium as in Example 6.
- phenyllithium is added to the resulting anion.
- the product can be isolated by distillation.
- 2-bromomethyl-6-methylpyridine is treated with dimethylamine to give the corresponding tertiary amine, 2-dimethylaminomethyl-6-methylpyridine.
- the tertiary amine is treated with cyanomethyl benzenesulfonate, as in Preparation II, to give dimethylcyanomethyl-(6-methyl-2-picolyl) ammonium benzene sulfonate,
- the quaternary ammonium salt is rearranged using sodium hydride and alkylated with benzylbromide according to the procedure described in Preparation III.
- the alkylated cyanoamine is decyanated with sodium borohydride in ethanol to give the desired product which can be purified through its picrate.
- a 100 mg sample of the candidate compound was dissolved in 10 ml absolute ethanol. To the solution was added 40 ml tap water containing 0.5 ml of 1% surfactant. A 5 ml sample of each solution was sprayed on to replicate ivy cuttings infested with Aphids, The results, tabulated below in Table 1 were recorded 18 hours following the application of the sprays.
- mice LD 50 of the compounds in mice is a measure of their mammalian toxicity.
- the second column illustrates the effectiveness of the candidate compounds as insecticides as compared to nicotine, whereas the third column is the ratio of insecticidal effectiveness to mammalian toxicity. This ratio shows that the alkylated nicotines are more effective insecticides than nicotine in that they are considerably safer with regard to mammalian response.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Description
- The present invention relates to a group of novel nicotine analogues containing alkyl substituents ortho to the pyrrolidine ring. The synthetic procedures disclosed herein for the production of nicotine analogues constitute considerably shorter and more practical routes than those previously proposed. The novel compounds produced by the methods of the present invention are useful as insecticides.
- Nicotine has been used as an insecticide for many years (see, for example, D. E. H. Frear, "Chemistry of the Pesticides," 3rd Ed., D. Van Nostrand Co., New York, 1955). Although a number of natural as well as synthetic nicotinoids have been screened with regard to insecticidal activity, the vast majority are significantly less active than nicotine [see J. Yamamoto et al., Agr. Biol. Chem. 32, 1341 (1968)]. The analogues of nicotine which have been tested involve either the alteration of the pyrrolidine moiety of the molecule, or the replacement of the pyridine ring with a substituted aromatic ring. Almost no work has been carried out with regard to examining the effects of pyridine substituents on insecticidal activity. F. Haglid et al. Acta. Chem. Scand., 21, 329, (1967)] treated I-nicotine with methyllithium to yield a 5:1 mixture of 6-methylnicotine and 4-methylnicotine. The latter isomer was found to possess little or no nicotinic activity while 6-methylnicotine was identical in pharmacological activity to nicotine itself. This result indicates that the effect of a methyl group substituted ortho- to the pyrrolidine ring on the pyridine ring plays a major role in nicotinic acitivity in mammals; however the effect of such a methyl substituent on insecticidal activity has not been previously determined. The utlimate ability of an insecticide depends not only on its absolute insecticidal activity but also on its specificity; i.e., a compound with moderate insecticidal activity which is nontoxic to mammals would be desirable. As a consequence, the synthesis of ortho-alkylated nicotinoids and their evaluation as insecticides is of considerable interest. Haglid was unable to isolate 2-methylnicotine using the method referred to above; however, he presented evidence that indicates that a trace amount may have been present in the reaction mixture.
- No routes to 2-substituted nicotinoids exist in the literature. Because of the substituent pattern involved and the well known resistance of pyridine toward Friedel-Crafts alkylation or acylation, precursors to such compounds are difficult to prepare. In reality, the regiospecific synthesis of polysubstituted pyridines is a continuing problem in modern heterocyclic chemistry.
- The approach envisioned by the inventors for preparing 2-alkylnicotinoids involves the addition of an ortho substituent via the rearrangement of a monosubstituted pyridine. Although such reactions have not generally succeeded in pyridine chemistry, [see R. Paul and S. Tchelitcheff, Bull. Soc. Chem. Fr., 2134, (1968)], proper selection of the migrating moiety has made it possible to synthesize the desired 2-alkylnicotinoids. Preliminary results demonstrating the feasibility of these reactions have been published by the inventors in J. Org. Chem., 41, 2658, (1976). The paper describes a new synthetic process for the production of 2-alkyl-3-acylpyridines and 2-alkyl-3-formylpyridines via [2,3]-sigmatropic rearrangement of 1-cyanomethyl-1-(α-alkyl-2-picolyl) pyrrolidinium salts. The versatility of this procedure is evidenced by the fact that the a-cyanoamine initially obtained can be hydrolyzed to an aldehyde, reductively cleaved to an amine, or alkylated and hydrolyzed to a ketone.
- Similar reactions involving homocyclic chemistry have been reported by Mander and Turner in J. Org. Chem., 38, 2915, (1972), wherein the [2,3]-sigmatropic rearrangement of ylids derived from allylic-N-cyanomethylpyrrolidinium salts followed by hydrolysis of the products afforded p, y,- unsaturated aldehydes.
- The present invention concerns new and improved processes for the production of compounds represented by the formula:
- The invention also includes the resulting compounds of this formula, except that in the case of 2-methylnicotine it extends only to the isolated, substantially pure compound.
- The present invention may make use of novel intermediate products, some of which are useful in the production of compounds of Formula I and are represented by the formula:
- As used herein, "lower alkyl" means straight-chain or branched alkyl groups with 1 to 6 carbon atoms, for example methyl, ethyl, propyl, isopropyl, butyl, and the like, with methyl being preferred. "Alkaryl" means aromatic radicals containing between 7 and 10 carbon atoms such as tolyl or xylyl. "Phenylalkyl" includes radicals such as benzyl, phenylethyl or phenylpropyl. "Heterocyclic structures" are meant to include cyclic amines such as pyrrolidine, morpholine, pyridine or tetrahydropyridines.
- The compounds within the scope of the Formula I have two basic nitrogen atoms and can therefore form acid addition salts with inorganic and organic acids; for example, hydrochloric acid, acetic acid, maleic acid, p-toluenesulfonic acid or ethanesulfonic acid.
- The salts of the compounds within the scope of Formula I can also be in the form of hydrates, for example, mono, tri- or polyhydrate.
- The compounds of Formula I may be synthesized by two different but related processes. In the first and preferred process, a 2-halomethyl or substituted methylpyridine represented by the formula:
- The 2-haloalkylpyridine starting materials are readily available or may be synthesized by known methods. The 1-alkyl-2-cyanopyrrolidines are prepared by treatment of a 1-alkyl-2-pyrrolidinone with a reducing agent such as sodium aluminum hydride followed by reaction with ammonium cyanide. The 2 cyano-N-substituted 1,2,3,6-tetrahydropyridines are prepared according to methods described in J. Org. Chem., 29, 1647 (1964).
- The reaction is carried out by adding a 2-haloalkylpyridine to a 1-alkyl-2-cyanopyrrolidine dissolved in an aprotic polar solvent such as dimethylsulfoxide, acetonitrile, etc. The reaction is allowed to continue until salt formation is complete as determined by, for example, thin layer chromatography.
- The [2,3]-rearrangement (Schemes I, below) of the pyrrolidine moiety is achieved by diluting the product (VII) obtained above with an aprotic solvent such as tetrahydrofuran, dimethylsulfoxide, hexamethylphosphoric triamide, acetonitrile, and the like, with tetrahydrofuran being preferred, and then adding a strong nonnucleophilic base such as potassium-tert-butoxide, potassium hydride, sodium hydride, sodium amide, and the like. After an appropriate reaction time of about 4 to about 8 hours, the product is isolated by standard extraction techniques known in the art. Alternatively, the reaction can be carried out using a base such as sodium amide and liquid ammonia as the solvent. The latter method minimizes formation of side products which occur in certain examples. The crude 2-alkyl-2'-cyano- nicotine product (VIII) isolated by standard techniques, is then treated with a reducing agent such as lithium aluminum hydride, sodium borohydride, sodium cyanohydride and the like. Heating may be required to complete the reaction and the crude product is then isolated and may be further purified by standard techniques to yield the desired 2-alkylnicotinoids of Formula IX:
- In a similar manner, the [2,3]-rearrangement of the 1-alkyl-1-(2-picolyl or 2-a-alkylpicolyl)-2-cyano-1,2,3,6-tetrahydropyridinium halide is achieved by reaction, preferably with sodium amide in liquid ammonia. Reductive decyanation gives a N'-alkyl-2-substituted-anatabine of Formula X:
- An alternate process for making the compounds of Formula I is shown in Scheme II below:
- Alkylation of a 2-halopicoline with a secondary amine such as pyrrolidine yields 1-(2-picolyl)-pyrrolidine (XII). The reaction is generally carried out in an aprotic solvent with gentle heating followed by stirring at room temperature. The isolated and distilled product, 1-(2-picolyl)pyrrolidine is then converted to a crystalline, quaternary salt by reaction with a compound of the formula Z-CH2CN wherein Z is as defined hereinabove, in an aprotic solvent to yield the corresponding salt (XIII). The a-cyanoamine thus formed serves as the migrating moiety in a Sommelet-Hauser rearrangement when treated with an excess of a strong, nonnucleophilic base. The initial rearrangement product, a 2-alkyl-3-(1-cyano-1-pyrrolidinylmethyl)pyridine (XIV) is generally not isolated, but its formation may be confirmed by pmr spectroscopy. The compounds of Formula XIV may then be treated with one equivalent of a strong base, followed by alkylation with a haloalkylnitrile, and acid hydrolysis to give a 2-methyl-3 pyridyl cyanoalkyl ketone of Formula XV. The ketone thus formed may be cyclized under reducing conditions to yield compounds of Formula (XVI). The reduction can be carried out catalytically, by means of noble metal catalyst, for example, by means of platinum, or by means of Raney nickel catalyst under elevated pressure, for example, under a pressure of more than 2 atmospheres. The compounds of Formula I obtained in the manner described above are unsubstituted at the nitrogen, i.e. R4 is hydrogen. Alternatively, the a-cyanoamine resulting from the rearrangement may be reduced to the corresponding amine or treated with an organometallic reagent to form an alkylated amine.
- In yet another aspect of the present invention, when R2 of Formula I is an alkyl group other than methyl, for example, ethyl or propyl, the compound may be prepared by starting with the appropriate 2-a-alkylpicoline as previously described herein above (Scheme I and Scheme II), or in an alternate approach by further alkylation of R2. For example, 2-methylnicotine may be readily converted to 2-ethylnicotine by treatment with phenyllithium followed by alkylation with a haloalkyl such as metholiodide. In a similar manner, 2-methylnicotine may be converted to a 2-phenylalkylnicotine by treatment with phenyllithium and alkylation with a haloalkylphenyl moiety to yield a compound of Formula I, such as, for example, 2-phenylethyInicotine.
- The following examples are illustrative but not limitive of the compounds of this invention and the procedures for their preparation. Temperatures stated are in degrees centigrade and all reactions were run in an inert atmosphere such as nitrogen.
- To 20 g of 1-methyl-2-pyrrolidinone in 250 ml of dry tetrahydrofuran was added, over a period of one hour, 26 ml of a 70% solution of sodium bis-(methoxyethoxy)aluminum hydride in benzene at 0°C. The reaction mixture was stirred for an additional hour at 0°C and then for two hours at room temperature.
- A solution of 29.4 g of potassium cyanide in 340 ml of water was added and the resulting mixture was stirred overnight at room temperature. Thereafter it was refluxed for 30 minutes.
- The reaction mixture was cooled and the organic and aqueous phase separated. The aqueous phase was washed with 100 ml of ether. The ether and tetrahydrofuran phases were then combined and washed with two 100 ml portions of a saturated sodium chloride solution. The organic phase was dried over sodium sulfate and filtered preparatory to removal of solvent under reduced pressure. The residue was distilled to yield 10.0 g of 1-methyl-2-cyanopyrrolidine. The compound had a boiling point of 57-9° at 9.5 mm of Hg.
- To 20.0 g (0.124 mole) of 1-(2-picolyl)pyrrolidine, obtained via the alkylation of 2-bromomethylpyridine with pyrrolidine, in 100 ml of acetonitrile was added one equivalent of cyanomethyl benzenesulfonate in 50 ml of acetonitrile maintaining the temperature at about 25°. After the addition was complete, the reaction was stirred at room temperature for 18 hours. The acetonitrile was removed under reduced pressure and tetrahydrofuran was added. The crystalline product was collected by filtration and washed with tetrahydrofuran and ether. After air drying, the yield of colorless crystals was 38.5 g (86%), m.p. 118.5-120°.
- AnaL Calcd. for C18H21N3O2S: C, 60.14; H, 5.89; N, 11.69; S, 8.92
- Found: C, 60.40; H, 5.89; N, 11.72; S, 8.82
-
- A solution of 12.32 g (34.6 mmol) of 1-cyanomethyl-1-(2-picolyl)pyrrolidinium benzenesulfonate in 125 ml of dry dimethylsulfoxide was prepared and 290 ml of dry tetrahydrofuran was added. The solution was cooled to -10°, and 1.84 g (38.1 mmol) of 50% sodium hydride in mineral oil was added.
- The mixture was stirred at -5 to -10° for 0.5 hour and allowed to warm to room temperature over 1.5 hours. An additional 1.84 g (38.1 mmol) of 50% sodium hydride in mineral oil was added, the mixture was heated under reflux for 0.5 hour, and then cooled to 1µ°. A solution of 5.1 g (38 mmol) of 3-bromopropionitrile in 25 ml tetrahydrofuran was added over a 0.5 hour period and the reaction stirred for an additional 0.5 hour. The reaction mixture was filtered and concentrated under reduced pressure. The residue was dissolved in ether and the ethereal solution was washed three times with a saturated sodium chloride-potassium carbonate solution. The aqueous washes were discarded and the organic phase was filtered and dried over sodium sulfate. Evaporation of the solvent gave 8.17 g of a brown oil. To the oil were added 5 ml of tetrahydrofuran, 15 ml water, and 30 ml of acetic acid. The solution was stirred at 53° for 24 hours, the volume reduced to 20 ml under reduced pressure and acidified with 40 ml of 2.2. N HCI. The aqueous solution was washed with two portions of ether, basified with potassium carbonate, and extracted with methylene chloride. The methylene chloride solution was dried over magnesium sulfate and the solvent removed. The residue was distilled (147° at 0.1 mm Hg) to yield a yellow oil which crystallized on trituration with ether. The colorless crystals were collected and dried. The yield of product was 3.2 g (53%), m.p. 82-83.5°.
- Anal. Calcd. for C10H10N2O: C, 68.95; H, 5.79; N, 16.08
- Found: C, 69.13; H, 5.80; N, 16.13
-
- To 25.0 g (0.134 mol) of 2-( 1-pyrrolidinyl)-2-(2-pyridyl)acetonitrile, prepared by the reaction of pyridine-2-carboxaldehyde with potassium cyanide and pyrrolidinium perchlorate, in 75 ml dry dimethylsulfoxide and 200 ml tetrahydrofuran at -10° was added 7.75 g (0.161 mol) of 50% sodium hydride dispersion. After no further gas evolution was observed, a solution of 22.34 g (0.161 mol) of methyl iodide in 10 ml tetrahydrofuran was added over a 10 minute period. After addition had been completed, the reaction mixture was warmed to 40° for two minutes and cooled to 15°. Tile reaction mixture was filtered and the precipitate was washed with methylene chloride. The filtrates were combined, washed with saturated sodium chloride solution, and dried over sodium sulfate. Removal of the solvent gave 24.75 g (92%) of the crude product, 2-(1-pyrrolidinyl)-2-(2-pyridyl)propionitrile. The total crude product was dissolved in 500 ml 95% ethanol, cooled to 5° and treated with 9.3 g (0.245 mol) sodium borohydride. The reaction mixture was stirred at room temperature for 20 hours and then filtered. Removal of the solvent at reduced pressure gave a tan oil which was dissolved in hexane and dried over sodium sulfate. The hexane solution was then filtered and concentrated. The crude product was distilled (78-80°/0.2 mm Hg) to give 20.77 g (88%) of 1-(1-pyrrolidinyl)-1-(2-pyridyl)ethane.
- Anal. Calcd. for C11H16N2: C, 74.95; H, 9.15; N, 15.90
- Found: C, 74.93; H, 9.23; N, 15.81
-
- An ethereal solution of 2-bromomethylpyridine, obtained by treating 9.0 g (35.6 mmol) of 2-bromomethylpyridine hydrobromide with aqueous sodium bicarbonate, was added to 4.30 g (39 mmol) of 1-methyl-2-cyanopyrrolidine in 100 ml dimethylsulfoxide. The ether was removed at reduced pressure, and the solution was stirred at room temperature for 24 hrs. To the solution was added 500 ml dry tetrahydrofuran and, after cooling to -20°, 4.0 g (35.8 mmol) of freshly sublimed potassium-t-butoxide was added. The reaction mixture was stirred for 5 hours at -20°, after which the tetrahydrofuran was removed under reduced pressure. A mixture of 50 ml ether and 50 ml ice water was added and the organic phase was separated. The aqueous phase was further extracted, and the combined extracts washed with three 50 ml portions of saturated sodium chloride and 10 ml 50% potassium hydroxide, and then dried over sodium sulfate. Removal of the ether gave 3.74 g of a crude product which was dissolved in 60 ml ether and added to a slurry of 1.41 g (37 mmol) of lithium aluminum hydride in 120 ml ether maintained at 0°. The solution was stirred at 0° for 0.5 hour and then heated under reflux for 3 hours. After cooling to 0°, 15 ml of saturated potassium carbonate was added dropwise, and the resulting mixture was heated under reflux for 0.5 hour. The mixture was filtered, and the filtrate was extracted with two 10 ml portions of 20% aqueous acetic acid. The aqueous phase was then adjusted to pH 10 with 50% aqueous potassium hydroxide, and the basic solution was extracted with four 25 ml portions of ether. The ether extracts were combined, washed with saturated sodium chloride, and dried over sodium sulfate. After filtration and removal of the ether, the crude product was distilled (56-591/0.1 mm) to give 1.22 g (19.5%) of 2-methylnicotine which was a colorless liquid.
- Anal. Calcd. for C11H16N2: C, 74.95; H, 9.15; N, 15.90
- Found: C, 75.04; H, 9.06; N, 15.68
-
- To a solution of 3.15 g 2-methyl-3-pyridyl 2-cyanoethyl ketone (Preparation III) in 180 ml of ethanol saturated with ammonia was added 20 g of freshly prepared Raney nickel. The mixture was hydrogenated in a Parr apparatus at about 50 psi for 15 h. The reaction mixture was filtered to remove the catalyst and concentrated under reduced pressure. The residue was taken up in hexane and dried over Drierite. After filtration and removal of the solvent the residue was distilled. The fraction boiling at 100-105°/0.175 mm Hg, was collected to give 2.1 g (75%) of 2-methylnornicotine.
- Anal. Calcd. for C10H14N2: C, 74.03; H, 8.70; N, 17.27
- Found: C, 73.93; H, 8.75; N, 16.99
-
- To a solution of 22.09 g (82.7 mmol) 2-bromomethyl-6-methylpyridine hydrobromide in 40 ml water was added 40 ml methylene chloride and 6.95 g (82.7 mmol) sodium bicarbonate at 0°. The methylene chloride portion was separated and the aqueous solution extracted with three 50 ml portions of methylene chloride. The methylene chloride extracts were combined, dried over magnesium sulfate, filtered, and concentrated to 35 ml under reduced pressure. A 50 ml portion of tetrahydrofuran was added and the solution was again concentrated to 35 ml under reduced pressure. A solution of 10 g (91 mmol) of 1-methyl-2-cyanopyrrolidine in 100 ml dimethylsulfoxide was added and the solution was stirred overnight at room temperature. The dimethylsulfoxide was removed under reduced pressure to give a viscous yellow oil.
- The resulting oil was dissolved in 100 ml dimethylsulfoxide and 500 ml tetrahydrofuran and then cooled to -10°. To the solution was added 4.5 g (94 mmol) 50% sodium hydride dispersion. The reaction was stirred for 3.5 hours at 0° and 16 hours at room temperature. The reaction mixture was filtered and the solvent was removed under reduced pressure giving a tan oil containing some solid material. The oil was dissolved in a small amount of ether and the solution filtered to remove insolubles. The ether solution was washed three times with a basic saturated sodium chloride solution, dried over sodium sulfate, filtered and concentrated to give 14.96 g of an oil. The oil was dissolved in 300 ml 95% ethanol and 4.7 g (124 mmol) of sodium borohydride was added. The mixture was stirred at 0° for 1 hour and at room temperature for 2 hours. The reaction mixture was filtered and the precipitate was washed first with ethanol and then with ether. The filtrate was concentrated, taken up in ether and filtered to remove additional insolubles. The filtrate was extracted with three 20 ml portions of 20% acetic acid. The combined acid extracts were washed with ether, diluted with 11.3 ml of concentrated hydrochloric acid and concentrated to dryness. The residue was treated with 50% aqueous potassium hydroxide and extracted with three portions of ether. The ether extracts were combined and dried over sodium sulfate. Concentration of the ether solution gave 12.88 g of crude product which was distilled. A 6.2 g fraction boiling from 88-135°/0.25 mm Hg, was collected which was primarily the desired product with some contaminants present. Chromatography of this fraction on 200 g of basic alumina, activity grade I, with 2% ethyl acetate in hexane gave about 4.6 g of product. Distillation (63-64°/0.05 mm Hg) yielded 3.8 g (25%) of pure 2,6-dimethylnicotine.
- Anal. Calcd. for C12H18N2: C, 75.74; H, 9.54; N, 14.72
- Found: C, 75.61; H, 9.62; N, 14.64
-
- The preparation of 2-methyl-3-pyridyl-3-cyanopropyl ketone was carried out using the procedure described for the synthesis of 2-methyl-3-pyridyl 2-cyanomethyl ketone (Preparation III) except that 4-bromobutyronitrile was used instead of 3 bromopiopionitrile. A solution of 2.8 g of the ketone in 150 ml ammonia saturated ethanol was prepared and 10 g of freshly prepared Raney nickel was added. The mixture was hydrogenated for 20 hours in a Parr apparatus at 67 psi. The reaction mixture was worked up as in Example 2. The product was isolated by distillation (108-1120/0.2 mm Hg) to give 2.2 g (89%) of 2-methylanabasine.
- Anal. Calcd. for C11H16N2: C, 74.95; H, 9.15; N, 15.90
- Found: C, 75.04; H, 8.96; N, 15.81
-
- To 5.0 g (28.4 mmol) of 1-(1-pyrrolidinyl)-1-(2-pyridyl)ethane (Preparation IV) in 30 ml acetonitrile was added 5.6 g (28.4 mmol) of cyanomethyl benzenesulfonate. After standing three days the reaction mixture was concentrated on a rotary evaporator and then subjected to continuous ether extraction. The crude product was dried and transferred to a 500 ml three-necked flask to which about 250 ml anhydrous ammonia was added. The resulting solution was stirred at -35° and 1.45 g (37.2 mmol) of sodium amide was added. The reaction mixture was stirred for four hours at -35° and then allowed to warm to room temperature and stand overnight. Ether was added to the residue, and the resulting solution was washed with a saturated sodium chloride solution and dried over sodium sulfate. Removal of the solvent gave 4.88 g of a tan oil. The oil was dissolved in 70 ml dimethylsulfoxide and 300 ml tetrahydrofuran to which 1.48 g (30.8 mmol) of 50% sodium hydride dispersion was added. The mixture was heated under reflux for 30 minutes and then cooled to -10°. A solution of 1.48 g (30.8 mmol) of 3-bromopropionitrile in 10 ml tetrahydrofuran was added over a 15-minute period, the cooling bath was removed, and the reaction mixture was stirred for 1 hour. The mixture was filtered and the solvent was removed, first on the rotary evaporator and then under high vacuum. The residue was dissolved in ether, and the ethereal solution was washed with two portions of 50% potassium hydroxide solution and one portion of saturated sodium chloride. The ether solution was dried over sodium sulfate and then concentrated to give 3.78 g of tan oil. The oil was dissolved in 5 ml tetrahydrofuran, 15 ml water and 30 ml glacial acetic acid. The solution was maintained at 53° overnight,, after which most of the solvent was removed on the rotary evaporator. Ether was added to the residue, and the ethereal solution was extracted with three 5 ml portions of 5% hydrochloric acid. The acid washes were combined and basified with potassium carbonate. The basic solution was extracted with methylene chloride. The methylene chloride extracts were combined and dried over sodium sulfate. Solvent was removed and the residue was distilled (150-50/0.05 mm Hg) to give 1 g of a yellow oil. A 500 mg sample of the crude product was dissolved in 100 ml absolute ethanol and the compound was hydrogenated at about 60 psi for 20 hours. The product was worked up as in Example 2, and purification was effected by preparative thin layer chromatography yielding 125 mg of a light yellow oil.
- AnaL Calcd. for C11H16N2: C, 74.95; H, 9.15; N, 15.90
- Found: C, 75.07; H, 9.25; N, 16.01
-
- To 176 mg (1 mmol) of 2-methylnicotine in 15 ml anhydrous ether was added 1.1 ml of 1.05 M phenyllithium solution. The reaction mixture was refluxed for 2.5 h after which it was cooled to -10° and 75 µl (1.2 mmol) methyl iodide was added. The solution was stirred overnight at room temperature. A few drops of methanol were added, the solution was filtered and the solvent was removed. The residue was dissolved in hexane, filtered once again, and the hexane was removed to give 70 mg of crude product. A gas chromatograph of the crude product showed a single major peak. Samples for elemental analysis and spectral data were obtained by preparative gas chromotography.
- Anal. Calcd. for C12H18N2: C, 75.74; H, 9.54; N, 14.72
- Found: C, 75.74; H, 9.70; N, 14.66
-
- To a solution of 8.09 g (31.9 mmol) of 2-bromo-methylpyridine hydrobromide in 15 ml water was added 25 ml methylene chloride. The mixture was cooled to 0° and a slight excess of sodium bicarbonate was added. The organic phase was separated and the aqueous phase was extracted with an additional 25 ml of methylene chloride. The organic phases were combined, extracted with two portions of saturated brine, dried over magnesium sulfate and filtered. To the filtered solution was added 3.89 g (31.9 mmol) of 1,2,3,6-tetrahydro-1-methyl-2-cyanopyridine and 50 ml tetrahydrofuran. The solution was concentrated to about 15 ml after which 30 ml dimethyl sulfoxide was added, and the reaction mixture was stirred for 21 hours. The solution was continuously extracted with ether and the ether insoluble residue was dissolved in methanol, transferred to a 500 ml three-necked flask, and evaporated in vacuo to dryness to give 7.33 g (79%) of a dark red semi-solid. Two hundred fifty ml of liquid ammonia was condensed into the flask and 1.23 g (31.4 mmol) of sodium amide was added. The reaction mixture was stirred at -60° for 30 minutes and then at reflux for 2 hours. The ammonia was allowed to boil off leaving a brown residue which was triturated with ether and the resulting ether solution was filtered, and concentrated to give 2.71 g of a brown oil. The oil was dissolved in 125 ml of 95% ethanol and 2.0 g of sodium borohydride was added. After stirring at room temperature for 8 hours, the ethanol was removed and the residue was dissolved in ether. The etheral solution was extracted with 5% hydrochloric acid, the acid solution was washed with ether, basified with aqueous potassium hydroxide, and extracted with ether. The ether extracts of the basic solution were combined, dried over magnesium sulfate, filtered, and the solvent was removed. The residue was distilled, and the fraction boiling at 95-1001/0.1 mm Hg was collected to give 800 mg of a yellow liquid which was primarily N',2-dimethylanatabine (80%). The impurity was not identified, but spectral data indicate that it too is a 2,3-disubstituted pyridine. Spectral data and elemental analyses were obtained from samples collected by preparative glc.
- Anal. Calcd. for C12H16N2: C, 76.55; H, 8.57; N, 14.88
- Found: C, 76.40; H, 8.65; N, 14.82
-
- 2-methyl-6-phenylpyridine, obtainable from 1,3-pentadiene and benzonitrile via the procedure of Janz and McColloch [J. Am. Chem. Soc., 77 (1955), 3413] is treated with N-bromosuccinimide to give 2-bromomethyl-6-phenylpyridine. The bromomethyl compound is treated with 1-methyl-2-cyanopyrrolidine, and the resulting salt is rearranged using sodium amide in liquid ammonia and decyanated with sodium borohydride in ethanol according to the procedures described in Example 1. The product can be purified by distillation.
- 2-methylnicotine is treated with phenyllithium as in Example 6. To the resulting anion is added a slight excess of benzyl bromide. The product can be isolated by distillation.
- 2-bromomethyl-6-methylpyridine is treated with dimethylamine to give the corresponding tertiary amine, 2-dimethylaminomethyl-6-methylpyridine. The tertiary amine is treated with cyanomethyl benzenesulfonate, as in Preparation II, to give dimethylcyanomethyl-(6-methyl-2-picolyl) ammonium benzene sulfonate, The quaternary ammonium salt is rearranged using sodium hydride and alkylated with benzylbromide according to the procedure described in Preparation III. The alkylated cyanoamine is decyanated with sodium borohydride in ethanol to give the desired product which can be purified through its picrate.
- 1-cyanomethyl-1-(2-picolyl)pyrrolidinium benzenesulfonate (see Preparation II) is rearranged and alkylated with 3-bromopropionitrile as in Preparation III. The resulting dicyanoamine is decyanated with sodium borohydride in ethanol to give the product. Purification is effected via the picrate.
- A 100 mg sample of the candidate compound was dissolved in 10 ml absolute ethanol. To the solution was added 40 ml tap water containing 0.5 ml of 1% surfactant. A 5 ml sample of each solution was sprayed on to replicate ivy cuttings infested with Aphids, The results, tabulated below in Table 1 were recorded 18 hours following the application of the sprays.
- Most of the compounds exhibited less toxicity to aphids than I-nicotine. However, all compuunds exhibited a significantly lower mammalian toxicity than /-nicotine. Aphid toxicity and mammalian toxicity can be taken into account simultaneously by examining the ratio of insecticidal toxicity to mammalian toxicity.
- Relevant data are shown in Table II below. In the first column, the LD50 of the compounds in mice is a measure of their mammalian toxicity. The second column illustrates the effectiveness of the candidate compounds as insecticides as compared to nicotine, whereas the third column is the ratio of insecticidal effectiveness to mammalian toxicity. This ratio shows that the alkylated nicotines are more effective insecticides than nicotine in that they are considerably safer with regard to mammalian response.
-
- The above results demonstrate that with regard to common houseflies, 2-methylnicotine is as effective an insecticide as nicotine itself, while 2-methylnornicotine is only slightly less effective. It is to be noted that previous results demonstrated that 2-methylnicotine possessed lower mammalian toxicity than nicotine.
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/805,689 US4155909A (en) | 1977-06-13 | 1977-06-13 | 2-Alkyl nicotinoids and processes for their production |
US805689 | 1977-06-13 | ||
US05/972,161 US4220781A (en) | 1977-06-13 | 1978-12-21 | Process for preparing 2-alkyl nicotinoids |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000106A1 EP0000106A1 (en) | 1978-12-20 |
EP0000106B1 true EP0000106B1 (en) | 1982-02-17 |
Family
ID=27122812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78300040A Expired EP0000106B1 (en) | 1977-06-13 | 1978-06-13 | 2-alkyl nicotinoids and processes for their production and use |
Country Status (3)
Country | Link |
---|---|
US (2) | US4155909A (en) |
EP (1) | EP0000106B1 (en) |
DE (1) | DE2759198A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321387A (en) * | 1980-03-21 | 1982-03-23 | Philip Morris, Incorporated | Process for the preparation of optically active nicotine analogs |
US4332945A (en) * | 1981-01-29 | 1982-06-01 | Philip Morris, Incorporated | Optically active nicotine analogs and process for their preparation |
US5015741A (en) * | 1989-10-03 | 1991-05-14 | Philip Morris Incorporated | Nicotine analogs |
ES2153357T3 (en) * | 1991-03-01 | 2001-03-01 | Univ Florida | USE OF NICOTINAL ANALOGS FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE NERVOUS SYSTEM. |
US5977144A (en) * | 1992-08-31 | 1999-11-02 | University Of Florida | Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
US5741802A (en) * | 1992-08-31 | 1998-04-21 | University Of Florida | Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
US5677459A (en) * | 1994-11-10 | 1997-10-14 | Sibia Neurosciences, Inc. | Methods for the preparation of modulators of acetylcholine receptors |
US5705512A (en) * | 1994-11-10 | 1998-01-06 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5703100A (en) * | 1994-11-10 | 1997-12-30 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5723477A (en) * | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5594011A (en) * | 1994-11-10 | 1997-01-14 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US6194581B1 (en) | 1995-04-07 | 2001-02-27 | Merck & Co., Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
US5794887A (en) | 1995-11-17 | 1998-08-18 | Komerath; Narayanan M. | Stagnation point vortex controller |
HUP0105124A3 (en) * | 1999-01-14 | 2002-05-28 | Merck & Co Inc | 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone and method for its preparation |
US7141673B1 (en) | 1999-01-14 | 2006-11-28 | Lonza Ag | 1-(6-methylpyridine-3-yl)-2-[4-(methylsulphonyl) phenyl] ethanone and method for its preparation |
SE0000933D0 (en) * | 2000-03-21 | 2000-03-21 | Independent Pharmaceutica Ab | Method of producing 6-substituted (S) -nicotine derivatives and intermediate compounds |
TWI335332B (en) * | 2001-10-12 | 2011-01-01 | Theravance Inc | Cross-linked vancomycin-cephalosporin antibiotics |
US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US8039459B2 (en) * | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
EP3313173A1 (en) | 2015-06-26 | 2018-05-02 | Altria Client Services LLC | Compositions and methods for producing tobacco plants and products having altered alkaloid levels |
GB201515921D0 (en) * | 2015-09-08 | 2015-10-21 | Parker Hannifin Mfg Uk Ltd | Method |
US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
-
1977
- 1977-06-13 US US05/805,689 patent/US4155909A/en not_active Expired - Lifetime
- 1977-12-31 DE DE19772759198 patent/DE2759198A1/en not_active Withdrawn
-
1978
- 1978-06-13 EP EP78300040A patent/EP0000106B1/en not_active Expired
- 1978-12-21 US US05/972,161 patent/US4220781A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE2759198A1 (en) | 1978-12-21 |
US4155909A (en) | 1979-05-22 |
EP0000106A1 (en) | 1978-12-20 |
US4220781A (en) | 1980-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0000106B1 (en) | 2-alkyl nicotinoids and processes for their production and use | |
US4115400A (en) | 1-Azoniabicyclo[3.1.0]hexanes | |
Taylor et al. | A general method of alkylation and alkenylation heterocycles | |
DE2814556C2 (en) | Substituted phenylacetic acid derivatives, processes for their preparation and pharmaceutical compositions containing them | |
US4081450A (en) | 1,3,4-Trisubstituted-4-arylpiperidines and their preparation | |
US4191771A (en) | Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines | |
Sundberg et al. | Lithiation of methoxyindoles | |
LU86435A1 (en) | NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
US5112826A (en) | Vasodilatory dihydrodibenzocycloheptyliden-ethylpiperazine derivatives | |
CS183391A3 (en) | Process for preparing dialkylpyridine-2,3-dicarboxylates and derivatives thereof | |
Adamson et al. | 212. Aminoalkyl tertiary carbinols and derived products. Part III. 3-Tertiary-amino-1-aryl-1-(2-pyridyl)-propan-1-ols and-prop-1-enes | |
Crook et al. | Piperidine Derivatives X. The Phenylpiperidylcarbinols | |
US3976660A (en) | Pyrrolidine derivatives | |
US4797496A (en) | Process for the preparation of pyrrolidone derivatives | |
FR2557570A1 (en) | NOVEL QUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | |
CH617934A5 (en) | ||
JP4538114B2 (en) | Novel process for the preparation of derivatives of 4-phenyl-1,2,3,6-tetrahydropyridine and intermediates used | |
Beyerman et al. | Synthetic neuromuscular‐and ganglion‐blocking agents. N‐Alkylated bipyridyls, bipiperidyls, and their methylene and ethylene “homologues” | |
US4758577A (en) | 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders | |
JPH07291974A (en) | Epi-epibatidine derivative and its preparation | |
JPS6257631B2 (en) | ||
US4167638A (en) | Process for production of 8-NHR quinolines | |
US4251659A (en) | Polyfluorohydroxyisopropyl-heterocyclic compounds | |
US5380858A (en) | Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists | |
HU183612B (en) | Process for producing new 4-quinoline-methan derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): CH FR GB |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH FR GB |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19830622 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19830711 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19840630 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19850228 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |